Tarsus Pharmaceuticals, Inc.
TARS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$116 | -$136 | -$62 | -$14 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $28 | $20 | $13 | $8 |
| Change in WC | $4 | $0 | -$1 | $1 |
| Other Non-Cash | -$0 | -$3 | $0 | $7 |
| Operating Cash Flow | -$83 | -$117 | -$49 | $4 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$2 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $144 | $0 |
| Inv. Purchases | -$266 | -$29 | -$149 | $0 |
| Inv. Sales/Matur. | $73 | $175 | $5 | $0 |
| Other Inv. Act. | -$5 | -$4 | -$144 | $0 |
| Investing Cash Flow | -$199 | $141 | -$145 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $40 | $10 | $19 | $0 |
| Stock Issued | $115 | $120 | $75 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $155 | $130 | $94 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$128 | $153 | -$100 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $225 | $72 | $171 | $168 |
| End Cash | $97 | $225 | $72 | $171 |
| Free Cash Flow | -$85 | -$123 | -$50 | $3 |